Bile Duct Carcinoma clinical trials

Explore recruiting bile duct carcinoma clinical trials.

Recruiting bile duct carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bile Duct Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, Open-Label, Multi-Drug, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Novel Immunomodulators as Monotherapy and in Combination with Anticancer Agents in Participants with Advanced Hepatobiliary Cancer (GEMINI-Hepatobiliary)

Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

PEARLDIFER - A Phase II study of pemigatinib after curative local therapy in locally advanced intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Bile Duct Carcinoma trials by city

Bile Duct Carcinoma clinical trials

Recruiting bile duct carcinoma studies right now

A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)

Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer

Target-specific immunoPET Imaging of Digestive System Carcinoma

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma

Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma

Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Accessories

Also recruiting in Europe

A Phase II, Open-Label, Multi-Drug, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Novel Immunomodulators as Monotherapy and in Combination with Anticancer Agents in Participants with Advanced Hepatobiliary Cancer (GEMINI-Hepatobiliary)

PEARLDIFER - A Phase II study of pemigatinib after curative local therapy in locally advanced intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements

Bile Duct Carcinoma trials by city

Other conditions